Drug Profile
Research programme: LAG-3 fusion proteins - Immutep Limited
Alternative Names: ImmuCcine®; IMP361; IMP362Latest Information Update: 28 Sep 2022
Price :
$50
*
At a glance
- Originator Immutep
- Class Membrane fusion proteins
- Mechanism of Action T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cervical cancer